** Index of Australian Healthcare stocks .AXHJ rises 1.9%, tracking broadly positive market sentiment .AX
** Bell Potter says that most healthcare firms remain unaffected from tariff impacts, but Nanosonics NAN.AX, Aroa ARX.AX, and Trajan TRJ.AX, which generate significant U.S. sales from international medical devices/equipment, may be susceptible
** Neuren NEU.AX, Clarity CU6.AX and Polynovo PNV.AX are among the top gainers on the sub-index, up 20%, 6.7% and 6.3% respectively
** Brokerage expects some impact on country's biggest pharma co CSL CSL.AX given fractionation of its unit's plasma-derived products across Australia, Germany, Switzerland and the U.S.
** Adds, tariffs could impact pharma cos, but lack of details complicates potential impact assessment
** Sub-index down 12.2% YTD, compared to 5% drop in benchmark ASX 200 .AXJO
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。